DNAnexus, Inc., a leader in precision health data platforms, and Oracle Health have announced a strategic collaboration to integrate genomic data into Oracle’s Electronic Health Record (EHR) system, enhancing precision medicine capabilities. Unveiled at the Oracle Health and Life Sciences Summit on September 11, 2025, this partnership aims to empower clinicians with real-time genomic insights for personalized patient care.
DNAnexus and Oracle integrate genomic data with Oracle Health EHR.
Enables clinicians to access genomic insights alongside patient medical history.
Supports continuous examination of genomic data for better treatment plans.
Non-binding agreement to redefine precision medicine at the point of care.
DNAnexus manages over 105 petabytes of data for global health organizations.
Announced at Oracle Health and Life Sciences Summit, September 11, 2025.
The collaboration integrates DNAnexus’ advanced genomics data infrastructure with Oracle Health’s EHR, enabling healthcare professionals to access and interpret genomic data alongside patient medical histories. “This collaboration is about enabling a new era of data-driven healthcare,” said Thomas Laur, CEO of DNAnexus. This integration will support continuous analysis of genomic results, helping clinicians understand adaptations that impact patient health and adjust treatment plans accordingly.
By combining DNAnexus’ expertise in managing multi-omic and real-world data with Oracle’s global EHR infrastructure, the partnership aims to create a learning health system that adapts in real time. “Arming physicians with insights based on the latest interpretations of genomic data will help improve patient care and advance our understanding of the relationship between care paths and care outcomes,” said Seema Verma, executive vice president and general manager of Oracle Health and Life Sciences. This system will provide actionable insights at the point of care, driving advancements in personalized medicine.
DNAnexus manages over 105 petabytes of data for a global network of pharmaceutical, diagnostic, academic, and government organizations. With over 45,000 users across 48 countries, its Precision Health Data Cloud supports scalable, secure data analysis and collaboration. This partnership leverages DNAnexus’ 15+ years of bioinformatics expertise to enhance Oracle’s EHR capabilities, ensuring secure and accessible genomic insights.
The non-binding agreement marks a significant step toward closing the genomics care loop, enabling continuous examination of clinical interpretations. This collaboration builds on a prior partnership announced in April 2024, which integrated DNAnexus’ platform with Oracle Cloud Infrastructure to accelerate genomic analysis. The latest integration is expected to redefine how clinicians use molecular data to deliver exceptional, personalized care.
For more details, attend the Oracle Health and Life Sciences Summit sessions: Unlock Discovery with AI-Powered Genomics (Sept. 11, 1:30-2:00 p.m. EDT) and Accelerating Precision Health: How DNAnexus and Oracle Are Closing the Genomics Care Loop (Sept. 11, 3:30-4:20 p.m. EDT) at https://www.oracle.com/health/health-life-scien....
DNAnexus, the enterprise platform for precision health data, accelerates the development, approval, and delivery of personalized treatments. With over 15 years of bioinformatics innovation, it powers a connected data ecosystem trusted by global precision health leaders, managing 105 petabytes of data for 45,000+ users across 48 countries.
Oracle offers integrated suites of applications and secure, autonomous infrastructure in the Oracle Cloud. Trusted by leading organizations worldwide, Oracle (NYSE: ORCL) drives innovation in healthcare and life sciences.
Also Read: Oracle's AI Cloud Revenue Projected at $144B
TechIntelPro empowers B2B technology decision-makers with the latest industry trends, deep insights, leadership perspectives and actionable intelligence to drive both organizational and professional milestones—and thrive on the tech pulse.